International Finance Corporation (IFC), a member of the World Bank Group, has committed a cornerstone equity investment of 197 billion rupiah (approximately $12 million) in the initial public offering (IPO) of PT Medela Potential Tbk, an Indonesian healthcare distributor and medical device manufacturer.
The investment is part of IFC’s broader strategy to deepen private sector participation in healthcare and to support Indonesia’s shift towards self-sufficiency in the production of essential medical products.
The funding will help Medela Potentia expand its reach across domestic and regional markets, upgrade its logistics infrastructure, and scale up manufacturing of medical devices—aligning with the government’s agenda to reduce import dependency and foster local production.
The IPO also marks a critical step for Medela Potentia in attracting more diversified capital and enhancing transparency through public market oversight. IFC’s participation is expected to elevate governance standards and send a strong signal to other investors exploring opportunities in Indonesia’s healthcare sector.
Since May 2023, IFC has partnered with the Ministry of Health through the Indonesian Health Sector Growth Program to catalyse private sector investment and foster stronger public-private collaboration in the health sector.
“This investment reinforces our commitment to expanding access to high-quality healthcare and pharmaceutical products and medical devices throughout Indonesia, while continuing to invest in technology, infrastructure, and innovation to meet the country’s growing healthcare needs,” Krestijanto Pandji, CEO of Medela Potentia, said in a statement.
“IFC’s investment reflects our commitment to strengthening Indonesia’s healthcare system,” added Euan Marshall, IFC’s Country Manager for Indonesia and Timor-Leste.
Through these strategic partnerships, IFC aims to foster sustainable, inclusive growth and contribute to Indonesia’s broader development priorities, including improved health outcomes and deeper private sector engagement.
Medela Potentia’s shares were officially listed on the Indonesia Stock Exchange (IDX) on April 15. The IPO raised 686 billion rupiah at an offer price of 188 rupiah apiece. Approximately 85.4% of the IPO proceeds will be allocated to its subsidiary, PT Anugrah Argon Medica, for loans and capital injections.
Around 10.7% will be directed to PT Deca Metric Medica as a capital injection, while the remainder will support GoApotik’s expansion of pharmacy partnerships and the development of various digital health initiatives.
With over 40 years of experience, Medela Potentia is a healthcare holding company that develops and manages a broad portfolio of pharmaceutical products, healthcare goods, and medical devices across diverse categories.
The company runs a fully integrated distribution business that covers importation, product registration, warehousing, distribution, cold-chain management, sales, and collection services. Its network spans Indonesia and Cambodia, serving over 3,000 hospitals, 23,000 pharmacies, 3,500 clinics, and more than 50,000 healthcare facilities.
In addition, the company offers marketing services for medical devices and owns facilities to manufacture selected types of medical products. It is also investing in digital platforms to modernise operations and enhance service quality for business partners and end-users.
IFC’s last announced investment for an Indonesian firm was in Feb 2025 when the lender, along with OCBC NISP, extended a $53 million sustainability-linked loan (SLL) to Warburg Pincus-backed retail and logistics property platform PT Nirvana Wastu Pratama (NWP) Property. It was IFC’s first sustainability loan in the country.
